7 Stocks Surging on Big Volume
05.29.12 | 01:27 PM
WINDERMERE, Fla. (Stockpickr) -- Professional traders running mutual funds and hedge funds don’t just look at a stock’s price moves; they also ...
A Troubling Lab Report 6-4-07
Updated:
06.02.07Views:
User Rating:
0.00/0RATE NOW
Log in to rate this portfolioFollow
Log in to follow
Description:
FANS OF ABBOTT LABORATORIES ARE FOCUSED on the company's launch of a new drug-coated cardiac stent, which they believe could trump competitors' products and snare up to 40% of the $5 billion market. Expectations for the product have helped fuel a 50% increase in the past 18 months in shares of the Abbott Park, Ill.-based health-care concern, which closed Friday at 56.30.But investors may be overlooking the fact that most of Abbott's profits come from its slower-growth, lower-multiple pharmaceutical division, not jazzy technologies. And some prominent doctors have started questioning the safety and efficacy of one of Abbott's best-selling drugs, TriCor, which helps patients lower triglycerides, a type of non-cholesterol fat.
Most Viewed Portfolios
View All
Articles
5 Stocks Set to Soar on Bullish Earnings
05.29.12 | 12:43 PM
WINDERMERE, Fla. (Stockpickr) – Short-sellers hate being caught short a stock that reports a blowout quarter. When this happens, we often see a t...
Recent Answers
The amount of debt is of huge importance for investors. The debt level is a capital capacity measure and something like a buffer for toug...
1 Answers
05.28.12 | 02:50 AM asked by DividendHero
Popular Forums
- Gold n Sliver overview...05.30.12 | 04:05 AM
- BANK NIFTY FUTURE LEVELS: TREND- BULLISH05.30.12 | 03:20 AM
- STOCK MARKET TODAY: 30TH MAY 201205.30.12 | 03:09 AM
- Keep an eye on the lucrative stocks05.30.12 | 01:33 AM
